These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 826484)

  • 1. Alkaline-extracted influenza subunit vaccine.
    Eckert EA
    Infect Immun; 1976 Dec; 14(6):1302-8. PubMed ID: 826484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A surface antigen influenza vaccine. 1. Purification of haemagglutinin and neuraminidase proteins.
    Brady MI; Furminger IG
    J Hyg (Lond); 1976 Oct; 77(2):161-72. PubMed ID: 1068195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine.
    Potter CW; Jennings R; Phair JP; Clarke A; Stuart-Harris CH
    J Infect Dis; 1977 Mar; 135(3):423-31. PubMed ID: 850080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic response to the influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. I. Studies in human vaccinees.
    Kilbourne ED; Cerini CP; Khan MW; Mitchell JW; Ogra PL
    J Immunol; 1987 May; 138(9):3010-3. PubMed ID: 3571981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation of the immune response to influenza virus subunit vaccines.
    Webster RG; Glezen WP; Hannoun C; Laver WG
    J Immunol; 1977 Dec; 119(6):2073-7. PubMed ID: 915292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and immunologic evaluation of neuraminidase-specific influenza A virus vaccine in humans.
    Ogra PL; Chow T; Beutner KR; Rubi E; Strussenberg J; DeMello S; Rizzone C
    J Infect Dis; 1977 Apr; 135(4):499-506. PubMed ID: 856917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VaxArray for hemagglutinin and neuraminidase potency testing of influenza vaccines.
    Kuck LR; Byrne-Nash R; Gillis J; Bueter K; Couzens LK; Eichelberger MC; Rowlen KL
    Vaccine; 2018 May; 36(21):2937-2945. PubMed ID: 29699789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immune responses to the hemagglutinin and neuraminidase antigens of influenza A virus after immunization in humans.
    Chow TC; Beutner KR; Ogra PL
    Infect Immun; 1979 Jul; 25(1):103-9. PubMed ID: 478632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protection of ferrets against influenza by immunization with a split influenza vaccine.
    Brady MI; Furminger IG
    Dev Biol Stand; 1975; 28():167-72. PubMed ID: 1126566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunogenic activity of the viral hemagglutinin and neuraminidase from live and inactivated influenza vaccines].
    Kustikova IuG; Gagarinova VM; Gorev NE; Shadrin AS
    Zh Mikrobiol Epidemiol Immunobiol; 1983 Apr; (4):79-84. PubMed ID: 6868890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterosubtypic protective immunity against influenza A virus induced by fusion peptide of the hemagglutinin in comparison to ectodomain of M2 protein.
    Staneková Z; Király J; Stropkovská A; Mikušková T; Mucha V; Kostolanský F; Varečková E
    Acta Virol; 2011; 55(1):61-7. PubMed ID: 21434706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A surface antigen influenza vaccine. 2. Pyrogenicity and antigenicity.
    Brady MI; Furminger IG
    J Hyg (Lond); 1976 Oct; 77(2):173-80. PubMed ID: 1068196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of highly concentrated influenza vaccine for use in novel delivery approaches.
    Kommareddy S; Bonificio A; Gallorini S; Baudner B; Singh M; O'Hagan D
    J Pharm Sci; 2013 Mar; 102(3):866-75. PubMed ID: 23303584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.
    Kamal RP; Blanchfield K; Belser JA; Music N; Tzeng WP; Holiday C; Burroughs A; Sun X; Maines TR; Levine MZ; York IA
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28768855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response.
    Johansson BE; Matthews JT; Kilbourne ED
    Vaccine; 1998; 16(9-10):1009-15. PubMed ID: 9682352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy of neuraminidase-specific and conventional influenza virus vaccines in induction of antibody to neuraminidase in humans.
    Kilbourne ED
    J Infect Dis; 1976 Oct; 134(4):384-94. PubMed ID: 789791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate.
    Venereo-Sanchez A; Gilbert R; Simoneau M; Caron A; Chahal P; Chen W; Ansorge S; Li X; Henry O; Kamen A
    Vaccine; 2016 Jun; 34(29):3371-80. PubMed ID: 27155499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purified influenza virus hemagglutinin and neuraminidase are equivalent in stimulation of antibody response but induce contrasting types of immunity to infection.
    Johansson BE; Bucher DJ; Kilbourne ED
    J Virol; 1989 Mar; 63(3):1239-46. PubMed ID: 2915381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivated influenza vaccine efficacy: diminished antigenicity of split-product vaccines in mice.
    Barry DW; Staton E; Mayner RE
    Infect Immun; 1974 Dec; 10(6):1329-36. PubMed ID: 4435958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.